Raj Long

An established multilingual senior executive with over 35 years of demonstrated success in regulatory, clinical development and accelerating access. Raj Long has considerable experience as a senior international regulatory executive in the pharmaceutical industry, combined with strategic experience as an advisor to the Department of Health & Social Care, European Union, Gates Foundation and World Health Organisation (WHO). Raj is currently a Deputy Director for pharmacovigilance and Gene Drive regulatory at the Gates Foundation and supports the WHO COVID-19 vaccine manufacturing taskforce as the regulatory co-lead.

During the Covid Pandemic Raj was Consultant Advisor to the Chief Scientist of the WHO, as well as being a WHO co-lead on the COVAX Task Force on COVID-19 mRNA vaccine manufacturing initiative.  Vice Chair of the World Dementia Council and has provided advice to numerous expert groups and government initiatives such as the G7 Global Action Against Dementia initiative and the Accelerated Access Review with NHS England. In her executive career, Raj held very senior international regulatory roles with responsibility for licensing innovative medicines in global pharmaceutical companies such as Bristol Myers Squibb, Novartis and GE Healthcare. As a recognition of Raj’s significant contributions TOPRA (Organisation for Regulatory Professionals) awarded Raj with the Lifetime Achievement Award in 2020. 

 Additionally, in 2021 the UK Government appointed Raj to the Medicines and Healthcare products Regulatory Agency Board (MHRA) as a Non-Executive Director further consolidating her unique blend of private/public health expertise.  In 2022, Raj was also appointed as an associate Executive Member of the to the newly formed UK Health Security Agency Board (UKHSA). In 2023, Raj was also appointed as an Expert Reviewer to the Innovative Health Initiative (IHI) by the EC.